Lord Collins of Highbury
Main Page: Lord Collins of Highbury (Labour - Life peer)Department Debates - View all Lord Collins of Highbury's debates with the Department for International Development
(5 years, 1 month ago)
Lords ChamberThe noble Baroness is right to highlight the benefits that the vaccine has brought. Previously, an outbreak of Ebola was passed on to four people; now, it is just one, following the vaccine. We should be very proud that UK aid played a part in developing that vaccine. We are working closely with the vaccine manufacturer and the Chief Medical Officer in the Department of Health and Social Care to ensure that we have enough. We are monitoring the numbers of vaccine that would be needed, and we are investing in further research to ensure that we are prepared for another outbreak.
My Lords, can I pay tribute to Rory Stewart, who went to Geneva and made the plea, made the pledge and encouraged other Governments to work on this? This disease knows no national boundaries, and it is important that we address the issue globally. The noble Baroness, Lady Hayman, mentioned the need to build community action and public health awareness, and we need to use every method of communication. In Sierra Leone, we used local radio, other projects and schools—changing behaviour was critical. In this very difficult situation of a war zone, can the Minister reassure us that we are able to build that community action?
I join the noble Lord in paying tribute to my right honourable friend Rory Stewart. He achieved a lot in his short time at DfID, passionately advocating for what 0.7% can do, putting climate and the environment at the heart of what we do and co-ordinating our response to Ebola and really pushing the agenda on that. I am sure that our new Secretary of State will continue that good work. The noble Lord is also right to point out the importance of communication. We are working on every angle of that, ensuring that we do so in the correct languages, using media where we can. I mentioned the anthropological research that we are doing, which is looking into how we can best spread the message, rather than the disease.